ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Denton A. Cooley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gentry, L. O.
Right arrow Articles by Cooley, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gentry, L. O.
Right arrow Articles by Cooley, D. A.

Ann Thorac Surg 1988;46:167-171
© 1988 The Society of Thoracic Surgeons


Articles

Antibiotic Prophylaxis in Open-Heart Surgery: A Comparison of Cefamandole, Cefuroxime, and Cefazolin

Layne O. Gentry, M.D.*, Barry J. Zeluff, M.D., Denton A. Cooley, M.D.

From the Infectious Diseases Section, St. Luke's Episcopal Hospital, and the Texas Heart Institute, Houston, TX.

Accepted for publication January 22, 1988.

* Address reprint requests to Dr. Layne Gentry, St. Luke's Episcopal Hospital, 6720 Bertner 2–233, Houston, TX 77030.

We undertook a prospective randomized evaluation of cefamandole nafate, cefuroxime sodium, and cefazolin sodium as prophylaxis in open-heart operations. A total of 903 patients having an elective procedure were enrolled in the study, and 620 of them were eventually considered evaluable. There were no significant differences between the three study groups. The overall rate of infection and the rate of infection according to demographic variables was not significantly different between the three antibiotics. Serious complications and deaths were also similar between the three agents. The presence of multiple severe underlying conditions was a risk factor for infection, independent of the antibiotic used. We conclude that there are no differences in the efficacies of the three agents in preventing postoperative infections in patients having open-heart operation. Cefuroxime, principally because of its every-12-hour dose, is far less expensive than cefamandole or cefazolin.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. A. Mangi, I. F. Palacios, and D. F. Torchiana
Catheter pericardiocentesis for delayed tamponade after cardiac valve operation
Ann. Thorac. Surg., May 1, 2002; 73(5): 1479 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Clinical Infectious DiseasesHome page
R. P. Gaynes, D. H. Culver, T. C. Horan, J. R. Edwards, C. Richards, J. S. Tolson, and National Nosocomial Infections Surveillance System
Surgical Site Infection (SSI) Rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System Basic SSI Risk Index
Clinical Infectious Diseases, September 1, 2001; 33(Supplement_2): S69 - S77.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. B. Mossad, J. M. Serkey, D. L. Longworth, D. M. Cosgrove III, and S. M. Gordon
Coagulase-Negative Staphylococcal Sternal Wound Infections After Open Heart Operations
Ann. Thorac. Surg., February 1, 1997; 63(2): 395 - 401.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Zickmann, A. Sablotzki, R. Fussle, G. Gorlach, and G. Hempelmann
PERIOPERATIVE MICROBIOLOGIC MONITORING OF TRACHEAL ASPIRATES AS A PREDICTOR OF PULMONARY COMPLICATIONS AFTER CARDIAC OPERATIONS
J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1213 - 1218.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
L. J. Miedzinski, J. C. Callaghan, E. A. Fanning, E. T. Gelfand, G. Goldsand, D. Modry, P. Penkoske, J. Preiksaitis, G. Sheehan, L. Sterns, et al.
Antimicrobial prophylaxis for open heart operations
Ann. Thorac. Surg., November 1, 1990; 50(5): 800 - 804.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. S. Gelfand, B. P. Simmons, P. Schoettle, O. B. Harrington, F. Martin, E. W. Owen, R. B. Craft, and N. Amarshi
Cefamandole versus cefonicid prophylaxis in cardiovascular surgery: A prospective study
Ann. Thorac. Surg., March 1, 1990; 49(3): 435 - 439.
[Abstract] [PDF]


Home page
JAMAHome page
D. S. Kernodle, D. C. Classen, J. P. Burke, and A. B. Kaiser
Failure of Cephalosporins to Prevent Staphylococcus aureus Surgical Wound Infections
JAMA, February 16, 1990; 263(7): 961 - 966.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The Society of Thoracic Surgeons.